Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Pulmonary rehabilitation in underground salt chambers for people with COPD

Official title: The Impact of Pulmonary Rehabilitation Conducted in Therapeutic Salt Chambers on the Clinical Status of Patients With Chronic Obstructive Pulmonary Disease (COPD)

Run by University School of Physical Education, Krakow, Poland · NCT07122544 · Data updated 2026-11-12

This program will try pulmonary rehabilitation sessions inside underground salt chambers to see if people with COPD breathe better, feel less symptomatic, and improve their fitness.

More COPD (Chronic Obstructive Pulmonary Disease) trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorUniversity School of Physical Education, Krakow, Poland
Academic / other
Locations1 site (Krakow, Małopolska)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2028
Registry record updatedNovember 26, 2025
Trial IDNCT07122544 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People with stable COPD who meet GOLD-based spirometric criteria (FEV1/FVC < 0.7, FEV1 ≥ 30% predicted), have a negative bronchodilator reversibility test, can participate in exercise, and can give informed consent would be appropriate candidates.

Probably not a fit

Patients with recent COPD exacerbation, respiratory failure or other major cardiac, neurologic, oncologic, or musculoskeletal contraindications (including implanted defibrillators or uncontrolled arrhythmias) are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program offers pulmonary rehabilitation and climatic (microclimate) therapy conducted in subterranean salt chambers characterized by cool, humid, highly ionized air. Participants take part in guided breathing exercises, general fitness training, relaxation sessions, and health education while clinical status and functional outcomes are measured before and after the intervention. Eligible participants must have COPD with post-bronchodilator FEV1/FVC < 0.7 and FEV1 ≥ 30% predicted and be able to perform the exercise program. The intervention is delivered at AKF Kraków in Krakow, Poland, using the underground salt-mine environment as an adjunct to standard rehabilitation techniques.

Why it matters

Potential benefit: If successful, this approach could reduce respiratory symptoms and improve exercise tolerance and quality of life for people with COPD.

How similar studies have gone: Small trials and observational reports of speleotherapy and subterranean microclimate therapies have suggested symptomatic or functional benefits for some respiratory conditions, but high-quality randomized evidence is limited and results are inconsistent.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* COPD diagnosis confirmed by a pulmonology specialist according to the 2025 GOLD guidelines.
* FEV1 ≥ 30% of the predicted value.
* FEV1/FVC \< 0.7 after bronchodilator administration in spirometry.
* Negative bronchodilator reversibility test.
* Voluntary written consent to participate in the study.

Exclusion Criteria:

* COPD exacerbation.
* Active cancer or a history of cancer within the past five years.
* Musculoskeletal disorders preventing independent movement and participation in exercise tests and training included in the study protocol.
* Recent (within six months) surgical procedure or trauma to the chest, abdomen, skull, brain, or eye area.
* Severe valvular heart disease.
* Implanted cardioverter-defibrillator.
* Diagnosed arrhythmias posing a risk of loss of consciousness.
* Acute coronary artery disease.
* Epilepsy.
* Uncontrolled arterial hypertension despite medication.
* Primary or secondary immunodeficiencies.
* Respiratory failure requiring chronic or intermittent oxygen therapy.
* Infectious diseases with fever during the experiment or within two weeks before the study.
* Claustrophobia.
* Pregnancy.
* Simultaneous participation in another rehabilitation program.
* Significant changes in pharmacological treatment during the study.

Where it's running

  • AKF Kraków
    Krakow, Małopolska, Poland
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.